TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07812805: SKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors

Sponsor: SK Life Science, Inc. · Phase: PHASE1 · Area: ONCOLOGY · Target Enrollment: 100 pts

Competing Trials Overlap

5 Active Trials

Excess Burn Exposure

$10,053,120

Rescue Site Savings

+$6,628,776

Unlock Full NCT07812805 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07812805 Rescue Dossier →